ClinicalTrials.Veeva

Menu

Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients (CKD)

W

Wonju Severance Christian Hospital

Status

Not yet enrolling

Conditions

Chronic Kidney Disease(CKD)
Depression

Treatments

Other: Antidepressants

Study type

Observational

Funder types

Other

Identifiers

NCT06675396
CKD Research Institute (Other Identifier)
CKD gene

Details and patient eligibility

About

By using genetic information we could predict the prevalence of mood disorder and response to treatment.

Full description

This prospective cohort study enrols patients with chronic kidney disease and gathers genetic information. By the patient's biochemical information, including genetic information, we could predict the prevalence of mood disorder and response to the antipsychotherapy.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • CKD patients aged 18 to 90 years

Exclusion criteria

  • no CKD patients, aged below 18 or above 90 years

Trial design

300 participants in 1 patient group

chronic kidney with mood disorder
Description:
Patients developed mood disorder after chronic kidney disease development
Treatment:
Other: Antidepressants

Trial contacts and locations

0

Loading...

Central trial contact

Jun Young Lee Lee Jun Young Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems